Improvement of comorbid anxiety and depression in patients with migraine treated with injectable preventive calcitonin gene-related peptide antagonists: Review of clinical evidence

Abubker Omaer; Abdulrazaq Albilali; Reem Bamogaddam; Fares Almutairi; Raghad Alsaif; Osama Almohammadi; Abdullah A Alhifany

doi:10.1016/j.jsps.2024.101989

Q1 2024

Improvement of comorbid anxiety and depression in patients with migraine treated with injectable preventive calcitonin gene-related peptide antagonists: Review of clinical evidence

Abubker Omaer · Abdulrazaq Albilali · Reem Bamogaddam · Fares Almutairi · Raghad Alsaif · Osama Almohammadi · Abdullah A Alhifany

10.1016/j.jsps.2024.101989 387 Views 7 Citations

Citations

387

Views

Abstract not available for this publication.

Cite this Article (APA)

Abubker, O., Abdulrazaq, A., Reem, B., Fares, A., Raghad, A., Osama, A., Abdullah, A. A. (2024). Improvement of comorbid anxiety and depression in patients with migraine treated with injectable preventive calcitonin gene-related peptide antagonists: Review of clinical evidence. Saudi Pharmaceutical Journal. https://doi.org/10.1016/j.jsps.2024.101989